LEO Foundation | News
22787
blog,ajax_fade,page_not_loaded,,select-child-theme-ver-1.0.0,select-theme-ver-1.8,wpb-js-composer js-comp-ver-4.3.5,vc_responsive

The LEO Foundation elects new Board members

Ballerup, Denmark, 30 March, 2017 – The LEO Foundation, a commercial foundation and the sole owner of the global healthcare company LEO Pharma, announces changes to its Board of Trustees. Eivind Kolding and Peter Schwarz have joined the Board of Trustees, replacing Per Håkon Schmidt and...

The LEO Foundation rewards young scientists in Japan

The LEO Foundation has offered awards to two young, promising Japanese scientists for their pioneering dermatological research. The awards have been bestowed in collaboration with the Japanese Society for Investigative Dermatology (JSID). Ballerup, Denmark (16 December 2016) – The LEO Foundation has recently presented the “LEO...

New research center will contribute to better drugs for skin disorders

Understanding how drugs interact with skin has long been a challenge within pharmaceutical research. Now, a new center at the Department of Pharmacy, UCPH, is set to become an international lighthouse in this research area, supported by a DKK 40 million grant from the LEO...

Developing deep understanding of atopic dermatitis

A Danish-American collaboration between Gentofte Hospital in Copenhagen and Mount Sinai in New York seeks unprecedented new opportunities to improve understanding of atopic dermatitis and hand dermatitis. Ballerup, Denmark (22 September, 2016) – Atopic dermatitis (AD) and hand dermatitis are heterogeneous disease entities and there has...